111 Capital Reduces Stake in Danaher Corporation $DHR

Institutional investor lowers position in conglomerate Danaher by over 75%

Published on Mar. 5, 2026

Got story updates? Submit your updates here. ›

111 Capital, an institutional investor, has reduced its stake in Danaher Corporation (NYSE:DHR) by 78.2% during the 3rd quarter. The firm now owns 1,287 shares of the conglomerate's stock, down from 5,908 shares previously, with the holdings valued at $255,000 at the end of the most recent quarter.

Why it matters

Danaher is a major diversified conglomerate with a wide range of products and services across life sciences, diagnostics, and environmental and applied solutions. Changes in institutional ownership can signal shifts in investor sentiment or portfolio strategy regarding the company.

The details

111 Capital sold 4,621 shares of Danaher during the 3rd quarter, lowering its total position to 1,287 shares. The firm's holdings in Danaher were worth $255,000 at the end of the quarter. Other institutional investors have also been active in trading Danaher shares, with some increasing and others decreasing their positions.

  • 111 Capital reduced its Danaher stake during the 3rd quarter of 2026.

The players

111 Capital

An institutional investment firm that has reduced its stake in Danaher Corporation.

Danaher Corporation

A global science and technology conglomerate that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets.

Got photos? Submit your photos here. ›

The takeaway

The reduction in 111 Capital's Danaher stake could signal a shift in the firm's investment strategy or portfolio positioning, though the reasons behind the move are not entirely clear from the information provided. Investors will likely continue to monitor changes in institutional ownership of Danaher as an indicator of broader market sentiment around the diversified conglomerate.